Septodont

Septocaine with Epinephrine Articaine HCl / Epinephrine Bitartrate 4% - 1:100,000 Injection Dental Cartridge 1.7 mL SA's #1 branded dental local anesthetic Local dental anesthesia in both simple and complex dental procedures. Features & benefits Septocaine® is the # 1 Branded Dental Anesthetic in the United States*. Septocaine and epinephrine 1:100,000 is preferred during operative or surgical procedures when improved visualization of the surgical field is desirable. Fast onset (1 to 9 minutes) to avoid delay before effective analgesia is achieved. Predictable duration of anesthesia: up to 60 minutes for infiltration injections and 120 minutes for nerve blocks. No-methylparaben formulation to avoid allergic reactions on sensitive patients. 100 percent latex-free components to help reduce allergic responses. Terminal sterilization of product/cartridges for safe use. Mylar label-covered glass cartridges to minimize the risk of wound in the event of a cartridge breakage. Cartridges packed 10 to a blister tray to avoid glass-to-glass contact, hence reducing breakage. * Source: SDM data Presentation Item #01A1400 - Box containing 5 blisters of 10 x 1.7ml glass cartridges Manufacturer # 01A1400 Brand Septocaine® with Epinephrine Manufacturer Septodont Country of Origin Canada Application Local Anesthetic Container Type Dental Cartridge Dosage Form Injection Generic Drug Name Articaine HCl / Epinephrine Bitartrate NDC Number 00362904902 Product Dating McKesson Acceptable Dating: we will ship >= 90 days Strength 4% - 1:100,000 Type Infiltration and Nerve Block UNSPSC Code 51273904 Volume 1.7 mL Product Information Description: Articaine 4% with Epinephrine 1:100,000. Box of 50 - 1.7 mL Cartridges. **Anesthetics are non-returnable. Manufacturer Code: 01-A1400 Brand: Septocaine Packaging: Package of 50 - 1.7 ml cartridges Type: Articaine 4% Vasoconstrictor: Epinephrine 1:100,000 The sale of this item may be subject to regulation by the U.S. Food and Drug Administration and state and local regulatory agencies. If the item is subject to FDA regulation, We will verify your status as an authorized purchaser of this item before shipping of the item.

Read more less

Septocaine - Articaine HCl 4% with Epinephrine 1:200,000. Box of 50 - 1.7 mL Cartridges. Suitable for most routine dental procedures. No-methylparaben formulation and latex free components help avoid allergic reactions on sensitive patients. Packages in 5 blister packs with 10 x 1.7ml glass cartridges each. **Anesthetics are non-returnable. Manufacturer Code: 01A1200 Brand: Septocaine Packaging: Package of 50 - 1.7 ml cartridges Type: Articaine 4% Vasoconstrictor: Epinephrine 1:200,000 Indications Local dental anesthesia in both simple and complex dental procedures. Features & benefits Septocaine® is the # 1 Branded Dental Anesthetic in the United States*. For most routine dental procedures Septocaine and epinephrine 1:200,000 is preferred. Fast onset (1 to 9 minutes ) to avoid delay before effective analgesia is achieved. Predictable duration of anesthesia : up to 60 minutes for infiltration injections and 120 minutes for nerve blocks. No-methylparaben formulation to avoid allergic reactions on sensitive patients. 100 percent latex free components to help reduce allergic responses. Terminal sterilization of product/cartridges for safe use. Mylar label covered glass cartridges to minimize risk of wound in the event of a cartridge breakage. Cartridges packed 10 to a blister tray to avoid glass to glass contact, hence reducing breakage. Item #01A1200 – Box containing 5 blisters of 10 x 1.7ml glass cartridges Manufacturer # 01A1200 Brand Septocaine® with Epinephrine Manufacturer Septodont Country of Origin Canada Application Local Anesthetic Container Type Dental Cartridge Dosage Form Injection Generic Drug Name Articaine HCl / Epinephrine Bitartrate NDC Number 00362904802 Product Dating McKesson Acceptable Dating: we will ship >= 90 days Strength 4% - 1:200,000 Type Infiltration and Nerve Block UNSPSC Code 51273904 Volume 1.7 mL The sale of this item may be subject to regulation by the U.S. Food and Drug Administration and state and local regulatory agencies. If the item is subject to FDA regulation, We will verify your status as an authorized purchaser of this item before shipping of the item.

Read more less

Ideal osteogenic matrix: designed through a special manufacturing process Fully synthetic Sterile and Fully resorbable. Hydroxyapatite & ß-Tricalcium phosphate are both fully resorbable This micro & macroporous structure mimics human bone Offers a high success rate with no risk of disease associated Will gradually generate new natural bone Biphasic formulations associating the very bioactive ß-Tricalcium Phosphate and the stable Hydroxyapatite that allows resorption at the right pace which leads in the creation of a new strong and qualitative bone. Two formulations available allowing you to manage the pace of your bone grafting procedures A proprietary micro and macroporous structure setting for an appropriate scaffold and allowing cellular colonization Bioactive and osteoconductive material providing a matrix for new bone growth Indications RTR+ is a bone graft material intended to be used to reconstruct bony loss or bone gaps in maxillofacial applications: following tooth extractions following intrabony/periodontal/peri-implants defects ridge augmentations sinus lifts cystic cavity fillings Presentation Item #01S0540 – R.T.R.+ 40/60 (40% β-Tricalcium Phosphate / 60% Hydroxyapatite) - One 0.5cc syringe

Read more less

RTR+ is a bone graft material intended to be used to reconstruct bony loss or bone gaps in maxillofacial applications: following tooth extractions following intrabony/periodontal/peri-implants defects ridge augmentations sinus lifts cystic cavity fillings Features & benefits Ideal osteogenic matrix: designed through a special manufacturing process Fully synthetic Sterile and Fully resorbable. Hydroxyapatite & ß-Tricalcium phosphate are both fully resorbable This micro & macroporous structure mimics human bone Offers a high success rate with no risk of disease associated Will gradually generate new natural bone Biphasic formulations associate the very bioactive ß-Tricalcium Phosphate and the stable Hydroxyapatite that allows resorption at the right pace which leads in the creation of a new strong and qualitative bone. Two formulations available allowing you to manage the pace of your bone grafting procedures A proprietary micro and macroporous structure setting for an appropriate scaffold and allowing cellular colonization Bioactive and osteoconductive material provides a matrix for new bone growth Presentation Item #01S0530 – R.T.R.+ 80/20 (80% β-Tricalcium Phosphate / 20% Hydroxyapatite) - One 0.5cc syringe

Read more less